General Statement of Disclosure: CONSULTING FEES/HONORARIA: Roche(MODEST), Reata(MODEST), Fresenius(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Otsuka Pharmaceutical Co.(MODEST) View Full Disclosure